|
CH503559A
(de)
|
1969-02-26 |
1971-02-28 |
Arx Paul Von |
Vorrichtung an Tafelschere zum Schneiden nach Markierungen, unter ständiger Beobachtung des Schnittes
|
|
GB9119920D0
(en)
|
1991-09-18 |
1991-10-30 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
BR9707495A
(pt)
|
1996-02-13 |
1999-07-27 |
Zeneca Ltd |
Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
|
|
US6291455B1
(en)
|
1996-03-05 |
2001-09-18 |
Zeneca Limited |
4-anilinoquinazoline derivatives
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
GB9714249D0
(en)
|
1997-07-08 |
1997-09-10 |
Angiogene Pharm Ltd |
Vascular damaging agents
|
|
GB9900334D0
(en)
|
1999-01-07 |
1999-02-24 |
Angiogene Pharm Ltd |
Tricylic vascular damaging agents
|
|
GB9900752D0
(en)
|
1999-01-15 |
1999-03-03 |
Angiogene Pharm Ltd |
Benzimidazole vascular damaging agents
|
|
SK288365B6
(sk)
|
1999-02-10 |
2016-07-01 |
Astrazeneca Ab |
Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy
|
|
NZ522074A
(en)
|
2000-05-31 |
2004-06-25 |
Astrazeneca Ab |
Indole derivatives with vascular damaging activity
|
|
UA73993C2
(uk)
|
2000-06-06 |
2005-10-17 |
Астразенека Аб |
Хіназолінові похідні для лікування пухлин та фармацевтична композиція
|
|
IL153484A0
(en)
|
2000-07-07 |
2003-07-06 |
Angiogene Pharm Ltd |
Colchinol derivatives as angiogenesis inhibitors
|
|
CN1255392C
(zh)
|
2000-07-07 |
2006-05-10 |
安吉奥金尼药品有限公司 |
作为血管生成抑制剂的秋水仙醇衍生物
|
|
AU2002305236A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kits for treatment of respiratory and lung disease with anti-sense oligonucleotides and a bronchodilating agent
|
|
SE0102808D0
(sv)
|
2001-08-22 |
2001-08-22 |
Astrazeneca Ab |
New compounds
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
MX2007003105A
(es)
|
2004-09-24 |
2007-06-07 |
Aztrazeneca Ab |
Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i.
|
|
MX2007013595A
(es)
|
2005-05-04 |
2008-01-24 |
Renovis Inc |
Compuestos heterociclicos fusionados y composiciones y usos de estos.
|
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
|
US20090099195A1
(en)
|
2007-05-08 |
2009-04-16 |
Astrazeneca Ab |
Therapeutic Compounds 570
|
|
CA2737038A1
(en)
|
2008-09-18 |
2010-03-25 |
Evotec Ag |
Amide compounds, compositions and uses thereof
|
|
BR112012011518B8
(pt)
|
2009-11-18 |
2023-01-10 |
Astrazeneca Ab |
Compostos, composição farmacêutica, kit e usos de um composto
|
|
WO2012158117A1
(en)
|
2011-05-17 |
2012-11-22 |
Astrazeneca Ab |
Combination therapies for treating pain
|
|
JP5893135B2
(ja)
|
2011-06-28 |
2016-03-23 |
ビボゾーン インコーポレイテッド |
多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途
|
|
US9598409B2
(en)
|
2013-01-31 |
2017-03-21 |
Neomed Institute |
Imidazopyridine compounds and uses thereof
|
|
WO2015021998A1
(en)
|
2013-08-15 |
2015-02-19 |
Volvo Truck Corporation |
Method and arrangement for balancing an energy storage system
|
|
RU2650118C2
(ru)
|
2013-08-23 |
2018-04-09 |
Афферент Фармасьютикалз Инк. |
Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
|
|
HUE058009T2
(hu)
|
2014-12-09 |
2022-06-28 |
Bayer Ag |
1,3-Tiazol-2-il szubsztituált benzamid-származékok
|
|
KR20180054843A
(ko)
|
2015-09-29 |
2018-05-24 |
애퍼런트 파마슈티컬스 인크. |
기침 치료에 사용하기 위한 디아미노피리미딘 p2x3 및 p2x2/3 수용체 조정제
|
|
US9907795B2
(en)
*
|
2016-01-08 |
2018-03-06 |
Nerre Therapeutics Limited |
Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents
|
|
MA43821A
(fr)
|
2016-03-14 |
2018-11-28 |
Afferent Pharmaceuticals Inc |
Pyrimidines et variantes de celles-ci, et leurs utilisations
|
|
US11186872B2
(en)
|
2016-03-17 |
2021-11-30 |
Cedars-Sinai Medical Center |
Methods of diagnosing inflammatory bowel disease through RNASET2
|
|
CN109996546B
(zh)
|
2016-09-30 |
2023-06-27 |
阿沙纳生物科学公司 |
P2x3和/或p2x2/3化合物及方法
|
|
US10111883B1
(en)
*
|
2017-09-18 |
2018-10-30 |
Bellus Health Cough Inc. |
Selective P2X3 modulators
|
|
CN108904507A
(zh)
|
2018-02-11 |
2018-11-30 |
赖英杰 |
P2x3受体调节剂苯并咪唑化合物在制备抗呼吸疾病药物中的应用
|
|
MX2021005424A
(es)
*
|
2018-11-13 |
2021-06-15 |
Bellus Health Cough Inc |
Formas cristalinas de un compuesto de imidazopiridina sustituida y uso del mismo como modulador del receptor p2x3.
|
|
WO2020112890A1
(en)
|
2018-11-29 |
2020-06-04 |
Cedars-Sinai Medical Center |
Rnaset2 compositions and methods of treatment therewith
|
|
WO2020135771A1
(zh)
|
2018-12-29 |
2020-07-02 |
武汉朗来科技发展有限公司 |
杂环类化合物、中间体、其制备方法及应用
|
|
AU2020228760A1
(en)
|
2019-02-25 |
2021-09-23 |
Glaxosmithkline Intellectual Property (No. 3) Limited |
Treatment with P2X3 modulators
|
|
JP2023513373A
(ja)
|
2020-02-14 |
2023-03-30 |
べルス・ヘルス・コフ・インコーポレーテッド |
Ｐ２ｘ３修飾薬
|
|
EP4103572A4
(en)
|
2020-02-14 |
2024-03-06 |
Bellus Health Cough Inc. |
MAKING A P2X3 ANTAGONIST
|